Press Releases

Date	Title	PDF Version
Dec 11, 2007	PNH Patients With Lower Levels of Hemolysis, Mild Anemia and Minimal Transfusion Support Have Significant Disease Burden; Soliris(R) Therapy Provided Clinical Improvements in PNH Patients Regardless of Disease Severity
Dec 10, 2007	Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH
Dec 07, 2007	Alexion Pharmaceuticals to Present Data on Soliris® (Eculizumab) and PNH at the 2007 American Society of Hematology (ASH) Annual Meeting
Dec 04, 2007	Soliris(R) Demonstrates Reductions in Hemolysis and Improvements in Fatigue, Overall Quality of Life and Anemia in a Broad Population of PNH Patients
Nov 09, 2007	Alexion Pharmaceuticals to Present Data on Soliris(R) (Eculizumab) and PNH at the 2007 American Society of Hematology (ASH) Annual Meeting
Nov 06, 2007	Alexion to Present at Investor Conferences
Oct 25, 2007	Alexion Reports Third Quarter 2007 Results
Oct 11, 2007	Alexion Pharmaceuticals Invites You to Participate in its Third Quarter 2007 Results Conference Call and Web Cast
Sep 04, 2007	Alexion to Present at Bear Stearns Healthcare Conference
Aug 20, 2007	PNH Patients Treated with Soliris® Experienced Dramatic Reduction in Blood Clots During Clinical Trials

Search